您的购物车当前为空
vMIP-II (1-21) 作为CXCR4的拮抗剂,与CC和CXC类趋化因子受体具有广谱性的相互作用。它在IC50为190 nM的条件下,与125I-SDF-1R进行CXCR4的竞争性结合。

vMIP-II (1-21) 作为CXCR4的拮抗剂,与CC和CXC类趋化因子受体具有广谱性的相互作用。它在IC50为190 nM的条件下,与125I-SDF-1R进行CXCR4的竞争性结合。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
vMIP-II (1-21) 相关产品
| 产品描述 | vMIP-II (1-21), a CXCR4 antagonist, exhibits broad-spectrum interaction with both CC and CXC chemokine receptors, specifically binding to CXCR4. It competes for CXCR4 binding of 125I-SDF-1R with an IC 50 value of 190 nM [1]. |
| 分子量 | 2425.84 |
| 分子式 | C108H169N33O27S |
| CAS No. | 265650-93-9 |
| Sequence | Leu-Gly-Ala-Ser-Trp-His-Arg-Pro-Asp-Lys-Cys-Cys-Leu-Gly-Tyr-Gln-Lys-Arg-Pro-Leu-Pro |
| Sequence Short | LGASWHRPDKCCLGYQKRPLP |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容